University of Nevada, Las Vegas; Center for Academic Enrichment and Outreach
Las Vegas (Nev.)
Lung transplantation is the last recourse for patients with severe respiratory failure. However, transplantable lungs do not keep up with the demand, and 15.4% of patients die awaiting transplant. An alternative therapy is extracorporeal life support (ECLS), which uses a pump and an oxygenator to serve as a bridge to transplant. However, this technology limits ambulation and requires ICU care. This novel study implements pumpless arteriovenous (AV) ECLS technology to remove CO2 via the subclavian vessels, providing respiratory support and hypercapnia (excessive CO2 retention) sympton relief for patients while allowing ambulation.
Ambulance service; Extracorporeal membrane oxygenation; Lungs--Transplantation; Lungs--Transplantation--Patients; Respiratory insufficiency
Biomechanical Engineering | Mechanical Engineering | Medicine and Health Sciences
IN COPYRIGHT. For more information about this rights statement, please visit http://rightsstatements.org/vocab/InC/1.0/
Ambulatory Extracorporeal Arterioveous CO2 Removal via Subclavian Vessels.
Available at: https://digitalscholarship.unlv.edu/mcnair_posters/28